Open access

Abstract

5-Alkylamino derivatives of tetrazolo[1,5-a]quinazoline were obtained with high regioselectivity in the reaction of 5-azidotetrazolo[1,5-a]quinazoline (formally, 2,4-diazidoquinazoline) with long chain alkylamines. The obtained 5-aminoquinazoline derivatives were used in a copper catalyzed azide-alkyne 1,3-dipolar cycloaddition reaction to obtain series of 4-(alkylamino-2-(1,2,3-triazol-1-yl)quinazolines.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • [1] I. Khan A. Ibrar N. Abbas and A. Saeed “Recent advances in the structural library of functionalized quinazoline and quinazolinone scaffolds: Synthetic approaches and multifarious applications” European Journal of Medicinal Chemistry vol. 76 pp. 193–244 Apr. 2014. https://doi.org/10.1016/j.ejmech.2014.02.005

  • [2] H. Duan J. W. Lee S. W. Moon D. Arora Y. Li H.-Y. Lim and W. Wang “Discovery Synthesis and Evaluation of 24-Diaminoquinazolines as a Novel Class of Pancreatic β-Cell-Protective Agents against Endoplasmic Reticulum (ER) Stress” Journal of Medicinal Chemistry vol. 59 no. 17 pp. 7783–7800 Sep. 2016. https://doi.org/10.1021/acs.jmedchem.6b00041

  • [3] K. S. Van Horn X. Zhu T. Pandharkar S. Yang B. Vesely M. Vanaerschot J.-C. Dujardin S. Rijal D. E. Kyle M. Z. Wang K. A. Werbovetz and R. Manetsch “Antileishmanial Activity of a Series of N2N4-Disubstituted Quinazoline-24-diamines” Journal of Medicinal Chemistry vol. 57 no. 12 pp. 5141–5156 Jun. 2014. https://doi.org/10.1021/jm5000408

  • [4] SK. S. Van Horn W. N. Burda R. Fleeman L. N. Shaw and R. Manetsch “Antibacterial Activity of a Series of N2N4-Disubstituted Quinazoline-24-diamines” Journal of Medicinal Chemistry vol. 57 no. 7 pp. 3075–3093 Apr. 2014. https://doi.org/10.1021/jm500039e

  • [5] H.-J. Zhou J. Wang B. Yao S. Wong S. Djakovic B. Kumar J. Rice E. Valle F. Soriano M.-K. Menon A. Madriaga S. Kiss von Soly A. Kumar F. Parlati F. M. Yakes L. Shawver R. Le Moigne D. J. Anderson M. Rolfe and D. Wustrow “Discovery of a First-in-Class Potent Selective and Orally Bioavailable Inhibitor of the p97 AAA ATPase (CB-5083)” Journal of Medicinal Chemistry vol. 58 no. 24 pp. 9480–9497 Dec. 2015. https://doi.org/10.1021/acs.jmedchem.5b01346

  • [6] G. Rosse “Quinalozinones as Inhibitors of Class I PI3K Kinases” ACS Medicinal Chemistry Letters vol. 6 no. 1 pp. 15–16 Jan. 2015. https://doi.org/10.1021/ml500435u

  • [7] J. Zheng L. Chen M. Schwake R. B. Silverman and D. Krainc “Design and Synthesis of Potent Quinazolines as Selective β-Glucocerebrosidase Modulators” Journal of Medicinal Chemistry vol. 59 no. 18 pp. 8508–8520 Sep. 2016. https://doi.org/10.1021/acs.jmedchem.6b00930

  • [8] A. Kalniņa Ē. Bizdēna G. Kiselovs A. Mishnev and M. Turks “Structural Proof of Tetrazolo[15-a]quinazoline Derivatives and their Application in the Synthesis of 4-Amino-2-(123-triazol-1-yl)quinazolines*” Chemistry of Heterocyclic Compounds vol. 49 no. 11 pp. 1667–1673 Jan. 2014. https://doi.org/10.1007/s10593-014-1418-2

  • [9] V. P. Krivopalov S. G. Baram A. Y. Denisov and V. I. Mamatyuk “Azide-tetrazole tautomerism of diazidodiazines and their benzo analogs” Bulletin of the Academy of Sciences of the USSR Division of Chemical Science vol. 38 no. 9 pp. 1839–1844 Sep. 1989. https://doi.org/10.1007/bf00957773

Search
Journal information
Metrics
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 270 126 3
PDF Downloads 145 91 1